Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 40 articles: HTML format

Single Articles

May 2008
1. BINYAMIN L , Alpaugh RK, Hughes TL, Lutz CT, et al
   Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.
   J Immunol. 2008;180:6392-401.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. BARONE F , Bombardieri M, Rosado MM, Morgan PR, et al
   CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjogren's Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization.
   J Immunol. 2008;180:5130-40.
   PubMed     Related articles    Abstract available
   
   
   February 2008
3. THAUNAT O , Nicoletti A
   Comment on "Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjogren's Syndrome
   J Immunol. 2008;180:2007-2008.
   PubMed     Related articles   
   
   
   
4. TAWARA T , Hasegawa K, Sugiura Y, Harada K, et al
   Complement activation plays a key role in antibody-induced infusion toxicity in monkeys and rats.
   J Immunol. 2008;180:2294-8.
   PubMed     Related articles    Abstract available
   
   
   January 2008
5. DILILLO DJ , Hamaguchi Y, Ueda Y, Yang K, et al
   Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
   J Immunol. 2008;180:361-71.
   PubMed     Related articles    Abstract available
   
   
   November 2007
6. HUANG TH , Chintalacharuvu KR, Morrison SL
   Targeting IFN-{alpha} to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities.
   J Immunol. 2007;179:6881-8.
   PubMed     Related articles    Abstract available
   
   
   
7. SPILLMANN FJ , Beck-Engeser G, Wabl M
   Differentiation and Ig-allele switch in cell line WEHI-231.
   J Immunol. 2007;179:6395-402.
   PubMed     Related articles    Abstract available
   
   
   
8. TRUFFINET V , Pinaud E, Cogne N, Petit B, et al
   The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
   J Immunol. 2007;179:6033-42.
   PubMed     Related articles    Abstract available
   
   
   October 2007
9. BOMBARDIERI M , Barone F, Humby F, Kelly S, et al
   Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjogren's Syndrome.
   J Immunol. 2007;179:4929-4938.
   PubMed     Related articles    Abstract available
   
   
   
10. QIAO G , Lei M, Li Z, Sun Y, et al
    Negative Regulation of CD40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B.
    J Immunol. 2007;179:4473-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
11. WINTER D , Moser J, Kriehuber E, Wiesner C, et al
    Down-Modulation of CXCR3 Surface Expression and Function in CD8+ T Cells from Cutaneous T Cell Lymphoma Patients.
    J Immunol. 2007;179:4272-82.
    PubMed     Related articles    Abstract available
    
    
    
12. LI Y , Williams ME, Cousar JB, Pawluczkowycz AW, et al
    Rituximab-CD20 Complexes Are Shaved from Z138 Mantle Cell Lymphoma Cells in Intravenous and Subcutaneous SCID Mouse Models.
    J Immunol. 2007;179:4263-71.
    PubMed     Related articles    Abstract available
    
    
    
13. STEWART R , Wei W, Challa A, Armitage RJ, et al
    CD154 Tone Sets the Signaling Pathways and Transcriptome Generated in Model CD40-Pluricompetent L3055 Burkitt's Lymphoma Cells.
    J Immunol. 2007;179:2705-12.
    PubMed     Related articles    Abstract available
    
    
    
14. WANG X , Yuling H, Yanping J, Xinti T, et al
    CCL19 and CXCL13 Synergistically Regulate Interaction between B Cell Acute Lymphocytic Leukemia CD23+CD5+ B Cells and CD8+ T Cells.
    J Immunol. 2007;179:2880-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
15. LI J , Song W, Czerwinski DK, Varghese B, et al
    Lymphoma Immunotherapy with CpG Oligodeoxynucleotides Requires TLR9 Either in the Host or in the Tumor Itself.
    J Immunol. 2007;179:2493-500.
    PubMed     Related articles    Abstract available
    
    
    
16. OIZUMI S , Strbo N, Pahwa S, Deyev V, et al
    Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    J Immunol. 2007;179:2310-7.
    PubMed     Related articles    Abstract available
    
    
    
17. TONE Y , Kojima Y, Furuuchi K, Brady M, et al
    OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites.
    J Immunol. 2007;179:1760-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
18. BIRAGYN A , Schiavo R, Olkhanud P, Sumitomo K, et al
    Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity.
    J Immunol. 2007;179:1381-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
19. ELPEK KG , Lacelle C, Singh NP, Yolcu ES, et al
    CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model.
    J Immunol. 2007;178:6840-8.
    PubMed     Related articles    Abstract available
    
    
    May 2007
20. CITTERA E , Leidi M, Buracchi C, Pasqualini F, et al
    The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab.
    J Immunol. 2007;178:6616-23.
    PubMed     Related articles    Abstract available
    
    
    
21. BARBER MA , Zhang T, Gagne BA, Sentman CL, et al
    NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model.
    J Immunol. 2007;178:6140-7.
    PubMed     Related articles    Abstract available
    
    
    
22. PILLAI AB , George TI, Dutt S, Teo P, et al
    Host NKT Cells Can Prevent Graft-versus-Host Disease and Permit Graft Antitumor Activity after Bone Marrow Transplantation.
    J Immunol. 2007;178:6242-51.
    PubMed     Related articles    Abstract available
    
    
    April 2007
23. HILCHEY SP , De A, Rimsza LM, Bankert RB, et al
    Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25- and CD4+CD25- T Cells.
    J Immunol. 2007;178:4051-61.
    PubMed     Related articles    Abstract available
    
    
    
24. SCHJETNE KW , Fredriksen AB, Bogen B
    Delivery of antigen to CD40 induces protective immune responses against tumors.
    J Immunol. 2007;178:4169-76.
    PubMed     Related articles    Abstract available
    
    
    March 2007
25. CONDOMINES M , Hose D, Raynaud P, Hundemer M, et al
    Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.
    J Immunol. 2007;178:3307-15.
    PubMed     Related articles    Abstract available
    
    
    
26. LIU S , Breiter DR, Zheng G, Chen A, et al
    Enhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory molecules.
    J Immunol. 2007;178:3301-6.
    PubMed     Related articles    Abstract available
    
    
    February 2007
27. STEL AJ , Ten Cate B, Jacobs S, Kok JW, et al
    Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.
    J Immunol. 2007;178:2287-95.
    PubMed     Related articles    Abstract available
    
    
    
28. ROUE G , Perez-Galan P, Lopez-Guerra M, Villamor N, et al
    Selective Inhibition of I{kappa}B Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level.
    J Immunol. 2007;178:1923-1930.
    PubMed     Related articles    Abstract available
    
    
    January 2007
29. GURURAJAN M , Dasu T, Shahidain S, Jennings CD, et al
    Spleen tyrosine kinase (syk), a novel target of curcumin, is required for B lymphoma growth.
    J Immunol. 2007;178:111-21.
    PubMed     Related articles    Abstract available
    
    
    
30. CHEN Y , Pappu BP, Zeng H, Xue L, et al
    B Cell Lymphoma 10 Is Essential for Fc{epsilon}R-Mediated Degranulation and IL-6 Production in Mast Cells.
    J Immunol. 2007;178:49-57.
    PubMed     Related articles    Abstract available
    
    
    
31. ITO K , Takubo K, Arai F, Satoh H, et al
    Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes.
    J Immunol. 2007;178:103-10.
    PubMed     Related articles    Abstract available
    
    
    
32. HUANG LP , Lyu SC, Clayberger C, Krensky AM, et al
    Granulysin-mediated tumor rejection in transgenic mice.
    J Immunol. 2007;178:77-84.
    PubMed     Related articles    Abstract available
    
    
    December 2006
33. HASTINGS KT , Lackman RL, Cresswell P
    Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.
    J Immunol. 2006;177:8569-77.
    PubMed     Related articles    Abstract available
    
    
    
34. HILLIARD A , Hilliard B, Zheng SJ, Sun H, et al
    Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4.
    J Immunol. 2006;177:8095-102.
    PubMed     Related articles    Abstract available
    
    
    November 2006
35. CATTORETTI G , Shaknovich R, Smith PM, Jack HM, et al
    Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.
    J Immunol. 2006;177:6930-9.
    PubMed     Related articles    Abstract available
    
    
    October 2006
36. RAY DM , Akbiyik F, Phipps RP
    The Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Ligands 15-Deoxy-{Delta}12,14-Prostaglandin J2 and Ciglitazone Induce Human B Lymphocyte and B Cell Lymphoma Apoptosis by PPAR{gamma}-Independent Mechanisms.
    J Immunol. 2006;177:5068-76.
    PubMed     Related articles    Abstract available
    
    
    
37. SHEN L , Zhang C, Wang T, Brooks S, et al
    Development of Autoimmunity in IL-14{alpha}-Transgenic Mice.
    J Immunol. 2006;177:5676-86.
    PubMed     Related articles    Abstract available
    
    
    
38. NAGY ZS , Rui H, Stepkowski SM, Karras J, et al
    A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor.
    J Immunol. 2006;177:5032-40.
    PubMed     Related articles    Abstract available
    
    
    September 2006
39. DESCAMPS G , Wuilleme-Toumi S, Trichet V, Venot C, et al
    CD45neg but not CD45pos human myeloma cells are sensitive to the inhibition of IGF-1 signaling by a murine anti-IGF-1R monoclonal antibody, mAVE1642.
    J Immunol. 2006;177:4218-23.
    PubMed     Related articles    Abstract available
    
    
    
40. SNOW AL , Lambert SL, Natkunam Y, Esquivel CO, et al
    EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
    J Immunol. 2006;177:3283-93.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: